Torrent Pharmaceuticals Ltd TORNTPHARM

Morningstar Rating
₹4,767.30 −32.70 (0.68%)
View Full Chart

About Quantitative Ratings

Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.

Price vs Fair Value

TORNTPHARM is trading at a LOCK|vn@X?< premium.
Price
₹4,767.30
Fair Value
LOCK|h%.nskTtfVg
Uncertainty
LOCK|gT
1-Star Price
LOCK|#v.p#K$&MH
5-Star Price
LOCK|@#.jL!$d?
Economic Moat
LOCK|w^w?S
Capital Allocation
—

Trading Information

Previous Close Price
₹4,800.00
Day Range
₹4,717.30–4,810.50
52-Week Range
₹3,480.60–5,250.00
Bid/Ask
₹4,918.90 / ₹4,767.30
Shares Outstanding
380.37M
Market Cap
₹1.81T
Volume/Avg
357,701 / 527,081

Key Statistics

Price/Earnings (Normalized)
76.98
Price/Sales
10.76
Dividend Yield (Trailing)
0.80%
Dividend Yield (Forward)
0.80%
Dividend Payment Schedule
Mar, Jun
Total Yield
0.80%

Company Profile

Torrent Pharmaceuticals Ltd is a drug manufacturing company with a focus on the cardiovascular, central nervous system, Vitamins Minerals Nutrients (VMN), and gastrointestinal therapeutic areas. It operates through the Generic Formulation Business segment. Geographically, the business activities are carried out across Indian and International markets. Maximum revenue for the company is generated from its operations in India.
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
Stock Style Box
Large Core
Total Number of Employees
17,729

Valuation

Metric
TORNTPHARM
Price/Earnings (Normalized)
76.98
Price/Book Value
19.23
Price/Sales
10.76
Price/Cash Flow
54.93
Price/Earnings
TORNTPHARM

Financial Strength

Metric
TORNTPHARM
Quick Ratio
0.72
Current Ratio
1.13
Interest Coverage
5.52
Quick Ratio
TORNTPHARM

Profitability

Metric
TORNTPHARM
Return on Assets (Normalized)
—
Return on Equity (Normalized)
—
Return on Invested Capital (Normalized)
—
Return on Assets
TORNTPHARM

Drug Manufacturers - Specialty & Generic Industry Comparables

1-Day Chart
Name
Price
Morningstar Rating for Stocks
Capital Allocation
Economic Moat
Market Cap
Merck KGaA ADR
MKKGY
LOCK|$nWw!^^LOCK|#Yn^Z$66B
Teva Pharmaceutical Industries Ltd
TEVA
LOCK|^>J!dyzLOCK|M?smX$46B
Haleon PLC ADR
HLN
LOCK|>S#!pjLOCK|Cq<$38B
Zoetis Inc Class A
ZTS
LOCK|W<nB$N@LOCK|LW$29B
Viatris Inc
VTRS
LOCK|PLgLk&LOCK|q@w$20B
Elanco Animal Health Inc
ELAN
LOCK|tjPLOCK|Z>$11B
Dr Reddy's Laboratories Ltd ADR
RDY
LOCK|WJXp!!LOCK|!$y$10B
Hims & Hers Health Inc Ordinary Shares - Class A
HIMS
LOCK|v^&@<&<LOCK|wL^$7B
Prestige Consumer Healthcare Inc
PBH
LOCK|$pLtqM!LOCK|#>Wb$2B
Perrigo Co PLC
PRGO
LOCK|ms@?qplLOCK|%&$2B

Sponsor Center